University of Alberta, Cross Cancer Institute

Edmonton, Alberta T6G 2B7

2 studies enrolling now · 14 studies all time

What they study most

Bladder Cancer, Cachexia, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV, Central Nervous System Lymphoma, Cervical Cancer, Classical Hodgkin Lymphoma, Cutaneous Melanoma, Diffuse Large B-cell Lymphoma, GBM, Gastric Carcinoma

Studies at this site

DALY II USA/ MB-CART2019.1 for DLBCL — Recruiting now
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 — Running, not enrolling
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer — Stopped early
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) — Completed
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma — Completed
Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed
Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma — Completed
Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma — Completed
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy — Completed
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma — Status unconfirmed
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. — Completed
Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab — Completed
Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients — Completed